StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report sent to investors on Wednesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock.
Titan Pharmaceuticals Stock Performance
Shares of TTNP stock opened at $6.70 on Wednesday. Titan Pharmaceuticals has a 1-year low of $5.00 and a 1-year high of $16.60. The stock’s fifty day moving average price is $7.32 and its 200 day moving average price is $7.09.
Titan Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Titan Pharmaceuticals
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- AMD is Down 35%. Now is the Time to Buy the Dip
- Consumer Discretionary Stocks Explained
- Amazon Stands Tall: New Highs Are in Sight
- How to Effectively Use the MarketBeat Ratings Screener
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Titan Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.